Comparison of laboratory tests, ultrasound, or magnetic resonance elastography to detect fibrosis in patients with nonalcoholic fatty liver disease: a meta-analysis

Cited by (893)

Items 201–300 of 893

1. Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO)
   Giulio Marchesini, Elisabetta Bugianesi, Patrizia Burra, Fabio Marra, Luca Miele, Anna Alisi, Piero Vajro, Mario Masarone, Salvatore Petta, Marcello Persico et al. · 2021 · Digestive and Liver Disease
2. Epidemiology, natural history, and diagnosis of metabolic dysfunction-associated fatty liver disease: a comparative review with nonalcoholic fatty liver disease
   Eda Kaya, Yusuf Nadir Yilmaz · 2022 · Therapeutic Advances in Endocrinology and Metabolism
3. Cost-effectiveness of MRE versus VCTE in staging fibrosis for nonalcoholic fatty liver disease (NAFLD) patients with advanced fibrosis
   Kinpritma Sangha, Stephanie T. Chang, Ramsey C Cheung, Vibhas S. Deshpande · 2023 · Hepatology
4. Role of noninvasive tests in the prognostication of metabolic dysfunction-associated steatotic liver disease
   Yue Wang, Sherlot Juan Song, Yichong Jiang, Jimmy Che‐To Lai, Grace Lai‐Hung Wong, Vincent Wai‐Sun Wong, Terry Cheuk‐Fung Yip · 2024 · Clinical and Molecular Hepatology
5. Metabolic profiles and fibrosis of nonalcoholic fatty liver disease in the elderly: A community‐based study
   Tsung‐Po Chen, Michelle Lai, Wen‐Yuan Lin, Kuo‐Chin Huang, Kuen‐Cheh Yang · 2020 · Journal of Gastroenterology and Hepatology
6. NAFLD in type 2 diabetes mellitus: Still many challenging questions
   Simona Cernea, Itamar Raz · 2020 · Diabetes/Metabolism Research and Reviews
7. Diversity in NAFLD: A Review of Manifestations of Nonalcoholic Fatty Liver Disease in Different Ethnicities Globally
   Ma Ai Thanda Han, Qi Yu, Zaid Tafesh, Nikolaos Pyrsopoulos · 2020 · Journal of Clinical and Translational Hepatology
8. Diagnostic Efficacy of Serum Mac-2 Binding Protein Glycosylation Isomer and Other Markers for Liver Fibrosis in Non-Alcoholic Fatty Liver Diseases
   Se Young Jang, Won Young Tak, Soo Young Park, Young Oh Kweon, Yu Rim Lee, Gyeonghwa Kim, Keun Hur, Man‐Hoon Han, Won Kee Lee · 2020 · Annals of Laboratory Medicine
9. Multiparametric MR Is a Valuable Modality for Evaluating Disease Severity of Nonalcoholic Fatty Liver Disease
   Young‐Sun Lee, Yang Jae Yoo, Young Kul Jung, Ji Hoon Kim, Yeon Seok Seo, Hyung Joon Yim, In Hee Kim, Soo Yeon Lee, Baek‐hui Kim, Jeong Woo Kim et al. · 2020 · Clinical and Translational Gastroenterology
10. Fibrosis-4 Index vs Nonalcoholic Fatty Liver Disease Fibrosis Score in Identifying Advanced Fibrosis in Subjects With Nonalcoholic Fatty Liver Disease: A Meta-Analysis
    Marco Castellana, Rossella Donghia, Vito Guerra, Filippo Procino, Fabio Castellana, Roberta Zupo, Luisa Lampignano, Rodolfo Sardone, Giovanni De Pergola, Francesco Romanelli et al. · 2021 · The American Journal of Gastroenterology
11. Conventional ultrasound for diagnosis of hepatic steatosis is better than believed
    Christoph Frank Dietrich, Long Shi, Axel Löwe, Yi Dong, Andrej Potthoff, Zeno Adrian Sparchez, Andreas Teufel, Sabine Guth, Jonas Koch, Richard G Barr et al. · 2021 · Zeitschrift für Gastroenterologie
12. Non-invasive tests for liver fibrosis assessment in patients with chronic liver diseases: a prospective study
    Kessarin Thanapirom, Sirinporn Suksawatamnuay, Natthaporn Tanpowpong, Bundit Chaopathomkul, Supachaya Sriphoosanaphan, Panarat M. Thaimai, Nunthiya Srisoonthorn, Sombat Treeprasertsuk, Piyawat Komolmit · 2022 · Scientific Reports
13. SWOT analysis of noninvasive tests for diagnosing NAFLD with severe fibrosis: an expert review by the JANIT Forum
    Yoshihiro Kamada, Takahiro Nakamura, Satoko Isobe, Kumiko Hosono, Yukiko Suama, Yukie Ohtakaki, Arihito Nauchi, Naoto Yasuda, Soh Mitsuta, Kouichi Miura et al. · 2022 · Journal of Gastroenterology
14. Sequential Combination of FIB-4 Followed by M2BPGi Enhanced Diagnostic Performance for Advanced Hepatic Fibrosis in an Average Risk Population
    Mimi Kim, Dae Won Jun, Huiyul Park, Bo-Kyeong Kang, Yoshio Sumida · 2020 · Journal of Clinical Medicine
15. Advanced liver fibrosis and the metabolic syndrome in a primary care setting
    Andrew D. Schreiner, Jingwen Zhang, Valerie L. Durkalski‐Mauldin, Sherry Livingston, Justin E. Marsden, John Bian, Patrick D. Mauldin, William P. Moran, Don C. Rockey · 2021 · Diabetes/Metabolism Research and Reviews
16. Myeloid-derived growth factor alleviates non-alcoholic fatty liver disease alleviates in a manner involving IKKβ/NF-κB signaling
    Yan Ding, Xiaoli Xu, Biying Meng, Li Wang, Biao Zhu, Bei Guo, Jiajia Zhang, Lin Xiang, Jing Dong, Min Liu et al. · 2023 · Cell Death and Disease
17. Updated S2k clinical practice guideline on non-alcoholic fatty liver disease (NAFLD) issued by the German society of gastroenterology, digestive and metabolic diseases (DGVS)–April 2022–AWMF Registration No.: 021–025
    Authors, Collaborators: · 2022 · Zeitschrift für Gastroenterologie
18. Accuracy of imaging methods for steatohepatitis diagnosis in non‐alcoholic fatty liver disease patients: A systematic review
    Giulia Besutti, Luca V. C. Valenti, Guido Ligabue, Maria Chiara Bassi, Pierpaolo Pattacini, Giovanni Guaraldi, Paolo Giorgi Rossi · 2019 · Liver International
19. Advances in ultrasound elastography for nonalcoholic fatty liver disease
    Masato Yoneda, Yasushi Honda, Asako Nogami, Kento Imajo, Atsushi Nakajima · 2020 · Journal of Medical Ultrasonics
20. Effects of Cirrhosis and Diagnosis Scenario in Metabolic-Associated Fatty Liver Disease-Related Hepatocellular Carcinoma
    Vincent Lingzhi Chen, Ming‐Lun Yeh, Ju Dong Yang, Jennifer Leong, Daniel Q. Huang, Hidenori Toyoda, Yao‐Li Chen, Jennifer E. Guy, Mayumi Maeda, Pei‐Chien Tsai et al. · 2020 · Hepatology Communications
21. Comparison of two-dimensional shear wave elastography, magnetic resonance elastography, and three serum markers for diagnosing fibrosis in patients with chronic hepatitis B: a meta-analysis
    Bingtian Dong, Guorong Lyu, Yuping Chen, Guofu Lin, Huaming Wang, Ran Qin, Jionghui Gu · 2021 · Expert Review of Gastroenterology & Hepatology
22. A prospective 5-year study on the use of transient elastography to monitor the improvement of non-alcoholic fatty liver disease following bariatric surgery
    Shirley Yuk‐Wah Liu, Vincent Wai‐Sun Wong, Simon Kin‐Hung Wong, Grace Lai‐Hung Wong, Carol Man‐Sze Lai, Candice Chuen‐Hing Lam, Sally She‐Ting Shu, Henry Lik‐Yuen Chan, Enders K. Ng · 2021 · Scientific Reports
23. Association between Metabolic Dysfunction-associated Fatty Liver Disease and Cognitive Impairment
    Qiang Yu, Ruixin He, Haowen Jiang, Ji Wu, Zhifeng Xi, Kang He, Yongbo Liu, Tao Zhou, Mingxuan Feng, Ping Wan et al. · 2022 · Journal of Clinical and Translational Hepatology
24. SHOULD ROUTINE LIVER BIOPSY BE CONSIDERED IN BARIATRIC SURGICAL PRACTICE? AN ANALYSIS OF THE LIMITATIONS OF NON-INVASIVE NAFLD MARKERS
    Matheus Mathedi Concon, Martinho Antônio Gestic, Murillo Pimentel Utrini, Felipe David Mendonça Chaim, Elinton Adami Chaim, Everton Cazzo · 2022 · Arquivos de Gastroenterologia
25. Circulating miRNAs as Novel Diagnostic Biomarkers in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
    Changzhou Cai, Yiming Lin, Chaohui Yu · 2019 · Canadian Journal of Gastroenterology and Hepatology
26. A pragmatic non-invasive assessment of liver fibrosis in patients with psoriasis, rheumatoid arthritis or Crohn's disease receiving methotrexate therapy
    Jean‐Paul Cervoni, B. Alby-Lepresle, Delphine Weil, Peng Zhong, François Aubin, Daniel Wendling, Éric Toussirot, Lucine Vuitton, Franck Carbonnel, Raphaële Blondet et al. · 2020 · Clinics and Research in Hepatology and Gastroenterology
27. Prevalence of at-risk NASH and its association with metabolic syndrome in US adults with NAFLD, 2017–2018
    Julia Yang Payne, Naim Alkhouri, Phuc Le, Michael B. Rothberg, Prido Polanco, Celine Sakkal, Srinivasan Dasarathy · 2023 · Hepatology Communications
28. Liver fibrosis as a barometer of systemic health by gauging the risk of extrahepatic disease
    Amedeo Lonardo, Stefano Ballestri, György Baffy, Ralf Weiskirchen · 2024 · Metabolism and Target Organ Damage
29. Non-alcoholic fatty liver disease
    Wenhao Li, William Alazawi · 2020 · Clinical Medicine
30. Quantitative magnetic resonance imaging for chronic liver disease
    Guilherme Moura Cunha, Patrick J. Navin, Kathryn Jane Fowler, Sudhakar Kundapur Venkatesh, Richard L. Ehman, Claude B. Sirlin · 2021 · British Journal of Radiology
31. Association of liver fibrosis with cognitive test performance and brain imaging parameters in the UK Biobank study
    Neal S. Parikh, Hooman Kamel, Cenai Zhang, Ajay Kumar Gupta, David E. Cohen, Mony J. de Leon, Rebecca F. Gottesman, Costantino Iadecola · 2022 · Alzheimer s & Dementia
32. Serum high-sensitive C-reactive protein is a simple indicator for all-cause among individuals with MAFLD
    Jiaofeng Huang, Ming-Fang Wang, Yinlian Wu, Rahul Kumar, Su Lin · 2022 · Frontiers in Physiology
33. Risk Stratification for Sarcopenic Obesity in Subjects With Nonalcoholic Fatty Liver Disease
    Ho Soo Chun, Minjong Lee, Hye Ah Lee, Se‐Jin Lee, So-Yeon Kim, Ye Jun Jung, Chaewon Lee, Hyoeun Kim, Han Ah Lee, Hwi Young Kim et al. · 2022 · Clinical Gastroenterology and Hepatology
34. High expression of forkhead box protein C2 is associated with aggressive phenotypes and poor prognosis in clinical hepatocellular carcinoma
    Yuki Shimoda, Yasunari Ubukata, Tadashi Handa, Takehiko Yokobori, Takayoshi Watanabe, Dolgormaa Gantumur, Kei Hagiwara, Takahiro Yamanaka, Mariko Tsukagoshi, Takamichi Igarashi et al. · 2018 · BMC Cancer
35. Ultrasonographic Nonalcoholic Fatty Pancreas Is Associated with Advanced Fibrosis in NAFLD: A Retrospective Analysis
    Russell Evan Rosenblatt, Amit Mehta, David B. Snell, Erika Marie. Hissong, Andrea Siobhan Kierans, Sonal Rajesh Kumar · 2018 · Digestive Diseases and Sciences
36. MR Elastography: Practical Questions, From the AJR Special Series on Imaging of Fibrosis
    Meng Yin, Richard L. Ehman · 2023 · American Journal of Roentgenology
37. PNPLA3 rs738409 C>G Variant Predicts Fibrosis Progression by Noninvasive Tools in Nonalcoholic Fatty Liver Disease
    Grazia Pennisi, Rosaria Maria Pipitone, Calogero Cammà, Vito Di Marco, Vincenzo Di Martino, Federica Spatola, Rossella Zito, Antonio Craxı̀, Stefania Grimaudo, Salvatore Petta · 2020 · Clinical Gastroenterology and Hepatology
38. Noninvasive stratification of nonalcoholic fatty liver disease by whole transcriptome cell-free mRNA characterization
    Naga Chalasani, Shusuke Toden, John J. Sninsky, Richard P. Rava, Jerome V. Braun, Samer Gawrieh, Jiali Zhuang, Michael I. Nerenberg, Stephen R. Quake, Tara Maddala · 2021 · American Journal of Physiology-Gastrointestinal and Liver Physiology
39. Dynamics of Serum Retinol and Alpha-Tocopherol Levels According to Non-Alcoholic Fatty Liver Disease Status
    Dongsub Jeon, Minkook Son, Ju-Hyun Shim · 2021 · Nutrients
40. Transient elastography versus liver biopsy: discordance in evaluations for fibrosis and steatosis from a pathology standpoint
    Jiayun M. Fang, Jerome Cheng, Michael F. Chang, Joseph C. Ahn, Maria A. Westerhoff · 2021 · Modern Pathology
41. Liver stiffness measurement by magnetic resonance elastography is not affected by hepatic steatosis
    Jie Chen, Alina M. Allen, Terry M. Therneau, Jun Chen, Jiahui Li, Safa Hoodeshenas, Jingbiao Chen, Xin Lü, Zheng Zhu, Sudhakar Kundapur Venkatesh et al. · 2021 · European Radiology
42. Aspartate Aminotransferase to Platelet Ratio Index and Fibrosis-4 Index for Detecting Liver Fibrosis in Patients With Autoimmune Hepatitis: A Meta-Analysis
    Bingtian Dong, Yuping Chen, Guorong Lyu, Xiaocen Yang · 2022 · Frontiers in Immunology
43. Accuracy of prognostic serological biomarkers in predicting liver fibrosis severity in people with metabolic dysfunction-associated steatotic liver disease: a meta-analysis of over 40,000 participants
    Sergio Lopez Torrez, Camila Ospina Ayala, Paula Bayer Ruggiro, Caroline Abud Drumond Costa, Mário Bernardes Wagner, Alexandre Vontobel Padoin, Rita Mattiello · 2024 · Frontiers in Nutrition
44. EUS-guided shear wave elastography for fibrosis screening in patients with obesity and metabolic dysfunction–associated steatotic liver disease: a pilot study (with video)
    Thomas J. Wang, Pichamol Jirapinyo, Raj Shah, Kimberly F. Schuster, David James Papke, Christopher C. Thompson, Laura Doyon, David B. Lautz, Marvin K. Ryou · 2024 · Gastrointestinal Endoscopy
45. Two-dimensional shear wave elastography for significant liver fibrosis in patients with chronic hepatitis B: A systematic review and meta-analysis
    Hong Wei, Hanyu Jiang, Mou Li, Tong Zhang, Bin Song · 2020 · European Journal of Radiology
46. The Fatty Liver Assessment in Germany (FLAG) cohort study identifies large heterogeneity in NAFLD care
    Wolf Peter Hofmann, Peter Buggisch, Lisa A. Schubert, Nektarios Dikopoulos, Jeannette Schwenzer, Marion Muche, Gisela Felten, Renate Heyne, Patrick Ingiliz, Anna Hartmann Schmidt et al. · 2020 · JHEP Reports
47. Elevated Glycated Hemoglobin Is Associated With Liver Fibrosis, as Assessed by Elastography, in a Population‐Based Study of Mexican Americans
    Gordon P. Watt, Isela de la Cerda, Jen‐Jung Pan, Michael B. Fallon, Laura Beretta, Rohit Seth Loomba, Miryoung Lee, Joseph B. McCormick, Susan P. Fisher‐Hoch · 2020 · Hepatology Communications
48. What Does the Future Hold for Patients With Nonalcoholic Steatohepatitis: Diagnostic Strategies and Treatment Options in 2021 and Beyond?
    Naim Alkhouri, Monica A. Tincopa, Rohit Seth Loomba, Stephen A. Harrison · 2021 · Hepatology Communications
49. Validation of Non-invasive Fibrosis Scores for Predicting Advanced Fibrosis in Metabolic-associated Fatty Liver Disease
    Xiaoning Chen, George Boon‐Bee Goh, Jiaofeng Huang, Yinlian Wu, Ming-Fang Wang, Rahul Kumar, Su Lin, Yueyong Zhu · 2022 · Journal of Clinical and Translational Hepatology
50. An Innovative Ultrasound Technique for Early Detection of Kidney Dysfunction: Superb Microvascular Imaging as a Reference Standard
    Zaher Armaly, Munai Abu-Rahme, Safa Kinaneh, Basem Hijazi, Nayef Habbasshi, Suheil Artul · 2022 · Journal of Clinical Medicine
51. How to Identify Advanced Fibrosis in Adult Patients with Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) Using Ultrasound Elastography—A Review of the Literature and Proposed Multistep Approach
    Mădălina-Gabriela Țâru, Lidia Neamți, Vlad Țâru, Lucia Maria Procopciuc, Bogdan Procopeț, Monica Lupșor‐Platon · 2023 · Diagnostics
52. Population screening for cirrhosis
    Maja Sofie Thiele, Elisa Pose, Adrià Juanola, Jessica Leigh Mellinger, Pere Ginès · 2024 · Hepatology Communications
53. Association between liver fibrosis and cognition in a nationally representative sample of older adults
    Neal S. Parikh, Sonal Rajesh Kumar, Russell Evan Rosenblatt, Chen Zhao, David E. Cohen, Costantino Iadecola, Hooman Kamel · 2020 · European Journal of Neurology
54. Present and Future Perspectives in the Treatment of Liver Fibrosis
    Lucia Cerrito, Linda Galasso, Jacopo Iaccarino, Alessandro Pizzi, Fabrizio Termite, Giorgio Esposto, Raffaele Borriello, Maria Elena Ainora, Antonio Gasbarrini, Maria Assunta Zocco · 2025 · Pharmaceuticals
55. Iodine density Changes in Hepatic and Splenic Parenchyma in Liver Cirrhosis with Dual Energy CT (DECT): A Preliminary Study
    Jian Dong, Fuliang He, Lei Wang, Zhendong Yue, Tingguo Wen, Rengui Wang, Fuquan Liu · 2018 · Academic Radiology
56. Novel Serum Biomarkers for Noninvasive Diagnosis and Screening of Nonalcoholic Fatty Liver Disease-Related Hepatic Fibrosis
    Biaoyang Lin, Yingying Ma, Shengjun Wu, Yunhua Liu, Longgen Liu, Lihua Wu · 2019 · OMICS A Journal of Integrative Biology
57. Effects of Tamoxifen vs. Toremifene on fatty liver development and lipid profiles in breast Cancer
    Dandan Song, Yingying Hu, Biyu Diao, Rongrong Miao, Baodan Zhang, Yangjun Cai, Hanqian Zeng, Yuru Zhang, Xiaoqu Hu · 2021 · BMC Cancer
58. Machine learning improves the prediction of significant fibrosis in Asian patients with metabolic dysfunction‐associated steatotic liver disease – The Gut and Obesity in Asia (GO‐ASIA) Study
    Nipun Verma, Ajay Kumar. Duseja, Manu Mehta, Arka De, Huapeng Lin, Vincent Wai‐Sun Wong, Grace Lai‐Hung Wong, Ruveena Bhavani Rajaram, Wah‐Kheong Chan, Sanjiv Mahadeva et al. · 2024 · Alimentary Pharmacology & Therapeutics
59. FibroMeter scores for the assessment of liver fibrosis in patients with autoimmune liver diseases
    Kalliopi Zachou, Vasiliki Lygoura, Pinelopi Arvaniti, Georgios Giannoulis, Nikolaos Gatselis, George Κ. Koukoulis, George N. Dalekos · 2020 · Annals of Hepatology
60. Clinical Guidelines of the Russian Society for the Study of the Liver, Russian Gastroenterological Association, Russian Society for the Prevention of Non-Communicable Diseases, Russian Association of Endocrinologists, Russian Scientific Medical Society of Therapists, National Society of Preventive Cardiology, Russian Association of Gerontologists and Geriatricians on Non-Alcoholic Fatty Liver Disease
    Vladimir T Ivashkin, Oksana M. Drapkina, Marina V. Maevskaya, K. L. Raikhelson, Sergey V. Okovityi, М. С. Жаркова, V. R. Grechishnikova, Diana Ildarovna Abdulganieva, Sergey A. Alekseenko, M.D. Ardatskaya et al. · 2025 · Russian Journal of Gastroenterology Hepatology Coloproctology
61. Medium term post-bariatric surgery deficit of vitamin B12 is predicted by deficit at time of surgery
    Darlène Antoine, Zhen Li, Didier Quilliot, Marie‐Aude Sirveaux, David Meyre, Alice Mangeon, Laurent Brunaud, Jean‐Louis Guéant, Rosa‐Maria Guéant‐Rodriguez · 2020 · Clinical Nutrition
62. Association between the severity of liver fibrosis and cardiovascular outcomes in patients with type 2 diabetes
    Ho Soo Chun, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Yong‐ho Lee, Young Dae Kim, Seung Up Kim · 2020 · Journal of Gastroenterology and Hepatology
63. Diagnostic and Therapy of Nonalcoholic Fatty Liver Disease: A Narrative Review
    Elke Roeb · 2021 · Visceral Medicine
64. Beyond the Liver Function Tests: A Radiologist's Guide to the Liver Blood Tests
    Brandon M. Metra, Flavius F. Guglielmo, Dina L. Halegoua-DeMarzio, Jesse M. Civan, Donald G. Mitchell · 2021 · Radiographics
65. Liver Stiffness Measurements by 2D Shear-Wave Elastography: Effect of Steatosis on Fibrosis Evaluation
    Takashi Kumada, Hidenori Toyoda, Satoshi Yasuda, Sadanobu Ogawa, Tatsuya Gotoh, Takanori Ito, Toshifumi Tada, Junko Tanaka · 2022 · American Journal of Roentgenology
66. Identification of high-risk subjects in nonalcoholic fatty liver disease
    Christiane Stern, Laurent Castéra · 2022 · Clinical and Molecular Hepatology
67. Overall and subgroup prevalence of non-alcoholic fatty liver disease and prevalence of advanced fibrosis in the United States: An updated national estimate in National Health and Nutrition Examination Survey (NHANES) 2011-2018
    Tongtong Wang, Yuzhi Xi, Annaswamy Raji, Michael F. Crutchlow, Gail F. Fernandes, Samuel S. Engel, Xiao Zhang · 2023 · Annals of Hepatology
68. Taiwan Association for the Study of the Liver-Taiwan Society of Cardiology Taiwan position statement for the management of metabolic dysfunction- associated fatty liver disease and cardiovascular diseases
    Pin‐Nan Cheng, Wen‐Jone Chen, Charles Jia‐Yin Hou, Chih‐Lin Lin, Ming‐Ling Chang, Chia‐Chi Wang, Wei‐Ting Chang, Chao‐Yung Wang, Chun‐Yen Lin, Chung‐Lieh Hung et al. · 2023 · Clinical and Molecular Hepatology
69. Associations between metabolic hyperferritinaemia, fibrosis‐promoting alleles and clinical outcomes in steatotic liver disease
    Deepika Suresh, Ashley Li, Matthew J. Miller, Karn Wijarnpreecha, Vincent Lingzhi Chen · 2023 · Liver International
70. Sonic hedgehog-heat shock protein 90β axis promotes the development of nonalcoholic steatohepatitis in mice
    Weitao Zhang, Junfeng Lu, Lian‐Shun Feng, Hanyue Xue, Shiyang Shen, Shuiqing Lai, Pingping Li, Ping Li, Jian Kuang, Zhiwei Yang et al. · 2024 · Nature Communications
71. Analysis of three ultrasound elastography techniques for grading liver fibrosis in patients with chronic hepatitis B
    Xinping Ren, Shujun Xia, Zhongxin Ni, Weiwei Zhan, Jianqiao Zhou · 2018 · La radiologia medica
72. Liver fibrosis with two-dimensional shear-wave elastography in patients with autoimmune hepatitis
    Xian Xing, Yuling Yan, Yi Shen, Mei Xue, Xiaoze Wang, Xuefeng Luo, Li Yang · 2020 · Expert Review of Gastroenterology & Hepatology
73. Association between serum interleukin (IL)-12 level and severity of non-alcoholic fatty liver disease (NAFLD)
    Darmadi Darmadi, Riska Habriel Ruslie · 2020 · Romanian Journal of Internal Medicine
74. Association of Magnesium Intake with Liver Fibrosis among Adults in the United States
    Meng‐Hua Tao, Kimberly G. Fulda · 2021 · Nutrients
75. Current and Emerging Biomarkers and Imaging Modalities for Nonalcoholic Fatty Liver Disease: Clinical and Research Applications
    Theresa Hydes, Emily E. Brown, A. Hamid, Adrian Calvin Bateman, Daniel James Cuthbertson · 2021 · Clinical Therapeutics
76. Noninvasive Tests in the Assessment of NASH and NAFLD Fibrosis: Now and Into the Future
    Leon Anton Adams, Wah‐Kheong Chan · 2020 · Seminars in Liver Disease
77. A comprehensive analysis of microRNAs as diagnostic biomarkers for asthma
    Li Xu, Minhan Yi, Yun Long Tan, Zixun Yi, Yuan Zhang · 2020 · Therapeutic Advances in Respiratory Disease
78. Liver Fibrosis is Associated with Ischemic Stroke Risk in Women but not Men: The REGARDS Study
    Neal S. Parikh, Insu Koh, Lisa B. VanWagner, Mitchell S.V. Elkind, Neil A. Zakai, Mary Cushman · 2021 · Journal of Stroke and Cerebrovascular Diseases
79. Liver Fibrosis and Steatosis in Alström Syndrome: A Genetic Model for Metabolic Syndrome
    Silvia Bettini, Giancarlo Bombonato, Francesca Dassie, Francesca Favaretto, Luca Piffer, Paola Bizzotto, Luca Busetto, Liliana Chemello, Marco Senzolo, Carlo Merkel et al. · 2021 · Diagnostics
80. Diagnostic role of transient elastography in patients with autoimmune liver diseases: A systematic review and meta-analysis
    Hong Chen, Yue Shen, Shengdi Wu, Qin Zhu, Chengzhao Weng, Jun Zhang, Meixia Wang, Wei Jiang · 2023 · World Journal of Gastroenterology
81. An Assessment of the Feasibility, Patient Acceptance, and Performance of Point-of-Care Transient Elastography for Metabolic-Dysfunction-Associated Steatotic Liver Disease (MASLD): A Systematic Review and Meta-Analysis
    Taranika Sarkar Das, Xucong Meng, Mohamed Abdallah, Mohammad Bilal, Raiya Sarwar, Aasma Shaukat · 2024 · Diagnostics
82. Determinants of increased muscle insulin sensitivity of exercise-trained versus sedentary normal weight and overweight individuals
    Dominik Hans Pesta, Evrim Anadol, Theresia Sarabhai, Yvo J.M. Op den Kamp, Sofiya Gancheva, Nina Trinks, Oana‐Patricia Zaharia, Lucia Mastrototaro, Kun Lyu, Ivo Habets et al. · 2025 · Science Advances
83. CT predicts liver fibrosis: Prospective evaluation of morphology- and attenuation-based quantitative scores in routine portal venous abdominal scans
    Verena Carola Obmann, Nando Mertineit, Annalisa Berzigotti, Christina Marx, Lukas Ebner, Roland Kreis, Peter Vermathen, Johannes T. Heverhagen, Andreas Christe, Adrian Thomas Huber · 2018 · PLoS ONE
84. Mechanisms, screening modalities and treatment options for individuals with non‐alcoholic fatty liver disease and type 2 diabetes
    Hydes, T. J., Summers, N., Brown, E., Alam, U., Thomaides‐Brears, H., Wilding, J. P. H., Cuthbertson, D. J. · 2020 · Diabetic Medicine
85. Noninvasive staging of liver fibrosis: review of current quantitative CT and MRI-based techniques
    Won Hyeong Im, Ji Soo Song, Weon Jang · 2021 · Abdominal Radiology
86. Baseline homeostasis model assessment of insulin resistance associated with fibrosis progression in patients with nonalcoholic fatty liver disease without diabetes: A cohort study
    Dae-Jeong Koo, Mi Yeon Lee, Inha Jung, Sun Joon Moon, Hyemi Kwon, Se Eun Park, Eun‐Jung Rhee, Won‐Young Lee · 2021 · PLoS ONE
87. Leveraging cellular mechano-responsiveness for cancer therapy
    Jeongeun Hyun, Hae‐Won Kim · 2021 · Trends in Molecular Medicine
88. New FIB-4 and NFS cutoffs to guide sequential non-invasive assessment of liver fibrosis by magnetic resonance elastography in NAFLD
    Louise Torres, Alice Schuch, Larisse Longo, Bruna Bressan Valentini, Gabriela Schneider Galvão, Eduardo Luchese, Carlos Pinzon, Rodrigo Bartels, Mário Reis Álvares‐da‐Silva · 2022 · Annals of Hepatology
89. Comparative Accuracy of Clinical Fibrosis Markers, Hepascore and Fibroscan® to Detect Advanced Fibrosis in Patients with Nonalcoholic Fatty Liver Disease
    Luis Calzadilla Bertot, Gary P. Jeffrey, Bastiaan de Boer, Zhengyi Wang, Yi Huang, George Garas, Gerry C. MacQuillan, Michael Wallace, Briohny W. Smith, Leon Anton Adams · 2023 · Digestive Diseases and Sciences
90. Liver Ultrasound Elastography in Non-Alcoholic Fatty Liver Disease: A State-of-the-Art Summary
    Rosanna Villani, Pierluigi Lupo, Moris Sangineto, Antonino Davide Romano, Gaetano Serviddio · 2023 · Diagnostics
91. Prevalence and incidence of MAFLD and associated anthropometric parameters among prepubertal children of the Shanghai Birth Cohort
    Jing Zeng, Qian Jin, Jing Yang, Rui‐Xu Yang, Rui-Nan Zhang, Jian Zhao, Jian‐Gao Fan · 2023 · Hepatology International
92. Using the FIB-4, automatically calculated, followed by the ELF test in second line to screen primary care patients for liver disease
    Denis Ouzan, Guillaume Pénaranda, Malik Jlaiel, H. Joly, Jeremie Corneille · 2024 · Scientific Reports
93. Association between longitudinal biomarkers and major adverse liver outcomes in patients with non-cirrhotic metabolic dysfunction–associated steatotic liver disease
    Ying Shang, Camilla Akbari, Maja Dodd, Xiao Zhang, Tongtong Wang, Thomas Jemielita, Gail F. Fernandes, Samuel S. Engel, Patrik Nasr, Johan Vessby et al. · 2024 · Hepatology
94. Prevalence of Low FIB‐4 in MASLD‐Related Hepatocellular Carcinoma: A Multicentre Study
    Darren Jun Hao Tan, Nobuharu Tamaki, Beom Kyung Kim, Karn Wijarnpreecha, Majd Bassam Aboona, Claire Faulkner, Charlotte Kench, Shirin Salimi, Abdul‐Hamid Sabih, Wen Hui Lim et al. · 2024 · Alimentary Pharmacology & Therapeutics
95. Position statement on the diagnosis and management of non-alcoholic fatty liver disease
    Khalid Alswat, Hind I. Fallatah, Bandar Al‐Judaibi, Hussien Elsiesy, Waleed Al-hamoudi, Adel N. Qutub, Naif Alturaify, Abdullah M. S. Al‐Osaimi · 2019 · Saudi Medical Journal
96. Value of controlled attenuation parameter in fibrosis prediction in nonalcoholic steatohepatitis
    Jung Il Lee, Hyun Woong Lee, Kwan Sik Lee · 2019 · World Journal of Gastroenterology
97. The overview of the deep learning integrated into the medical imaging of liver: a review
    Kailai Xiang, Baihui Jiang, Dong Shang · 2021 · Hepatology International
98. Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO)
    Associazione Italiana per lo Studio del Fegato (AISF), Società Italiana di Diabetologia (SID) and Società Italiana dell’Obesità (SIO) · 2021 · Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity
99. ASMBS Position Statement on the Impact of Metabolic and Bariatric Surgery on Nonalcoholic Steatohepatitis
    Guilherme S. Mazzini, Toms Augustin, Sabrena F. Noria, Carlos Romero‐Marrero, Na Li, Bilal Hameed, Dan Eisenberg, Dan Elison Azagury, Sayeed Ikramuddin · 2021 · Surgery for Obesity and Related Diseases
100. Multidisciplinary lifestyle intervention is associated with improvements in liver damage and in surrogate scores of NAFLD and liver fibrosis in morbidly obese patients
     Monika Bischoff, Sebastian Zimny, Sebastian Feiner, Johannes Sauter, Svenja Sydor, Gerald Denk, Jutta Maria Nagel, Gert Bischoff, Christian Rust, Simon D. Hohenester · 2022 · European Journal of Nutrition